Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Expected to Post Q1 2022 Earnings of ($0.77) Per Share
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX – Get Rating) – Equities researchers at Wedbush issued their Q1 2022 EPS estimates for shares of Black Diamond Therapeutics in a research report issued on Tuesday, March 29th. Wedbush analyst R. Driscoll anticipates that the company will post earnings per share of ($0.77) for the quarter. Wedbush currently has […]